J Bryan, A Crane, WH Vila-Carriles, AP … - Current pharmaceutical design, 2005 - ingentaconnect.com Abstract: ATP-sensitive K + channels, termed K ATP channels, provide a link
between cellular metabolism and membrane electrical activity in a variety of
tissues. Channel isoforms have been identified and are targets for ... Cited by 38 - Related articles - BL Direct - All 4 versions
C Spirlì, R Fiorotto, L Song, J Santos-Sacchi … - Gastroenterology, 2005 - Elsevier Background & Aims: Progressive liver disease is a severe complication of cystic
fibrosis, a genetic disease characterized by impaired epithelial adenosine
3′,5′-cyclic monophosphate-dependent secretion caused by mutations in ... Cited by 12 - Related articles - All 16 versions
- ►diabetesjournals.org S Nagamatsu, M Ohara-Imaizumi, Y Nakamichi, … - Diabetes, 2006 - Am Diabetes Assoc Sulfonylurea and glinide drugs, commonly used for antidiabetes therapies, are
known to stimulate insulin release from pancreatic β-cells by closing
ATP-sensitive K + channels. However, the specific actions of these drugs on ... Cited by 5 - Related articles - BL Direct - All 5 versions
- ►endocrinology-journals.org NH McClenaghan, PR Flatt, AJ Ball - Journal of Endocrinology, 2006 - Soc Endocrinology This study examined the effects of glucagon-like peptide-1 (GLP-1) on insulin
secretion alone and in combination with sulphonylureas or nateglinide, with
particular attention to K ATP channel-independent insulin secretion. In ... Cited by 4 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org Z Ling, Q Wang, G Stangé… - Diabetes, 2006 - Am Diabetes Assoc Use of sulfonylureas in diabetes treatment is based on their insulin-releasing
effect on pancreatic β-cells. Prolonged action is known to degranulate
β-cells, but functional consequences have not been examined at the ... Cited by 2 - Related articles - BL Direct - All 5 versions
DR Casey, SC Sebai, GC Shearman, O Ces, … - Industrial and Engineering Chemistry Research, 2008 - imperial.ac.uk Page 1. Formulation Affects the Rate of Membrane Degradation Catalyzed by
Cationic Amphiphilic Drugs Duncan R. Casey,† Sarra C. Sebai ... Cited by 2 - Related articles - View as HTML - All 6 versions
L Brennan, C Hewage, JP Malthouse, NH … - FEBS JOURNAL, 2006 - interscience.wiley.com Prolonged exposure of pancreatic beta cells to the sulfonylureas glibencamide
and tolbutamide induces subsequent desensitization to the actions of these
drugs. The precise mechanisms underlying this desensitization remain ... Cited by 1 - Related articles - BL Direct - All 4 versions
M Lehtihet - polopoly9.it.ki.se Page 1. From the Department of Internal Medicine, The Endocrine and Diabetes Unit
Karolinska Institutet, Stockholm South Hospital, Stockholm, Sweden ... Related articles - All 8 versions
M von Kleist, C Kloft, W Huisinga - hamilton.ie Abstract: To increase the efficiency of drug discovery and development,
modelling and simulation in pharmacokinetics and disease is gaining increasing
attraction. Due to recent advances in physiologically based ... Related articles - All 2 versions
S Nagamatsu, M Ohara-Imaizumi, Y Nakamichi, … - DIABETES, 2006 - Am Diabetes Assoc Page 1. Original Article Imaging Docking and Fusion of Insulin Granules Induced
by Antidiabetes Agents Sulfonylurea and Glinide Drugs Preferentially Mediate the ... Related articles
